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A network of conserved proteases known as the intramitochondrial quality control (IMQC) system is central to mitochondrial
protein homeostasis and cellular health. IMQC proteases also appear to participate in establishment of signaling cues for mito-
chondrion-to-nucleus communication. However, little is known about this process. Here, we show that in Saccharomyces cerevi-
siae, inactivation of the membrane-bound IMQC protease Oma1 interferes with oxidative-stress responses through enhanced
production of reactive oxygen species (ROS) during logarithmic growth and reduced stress signaling via the TORC1-Rim15-
Msn2/Msn4 axis. Pharmacological or genetic prevention of ROS accumulation in Oma1-deficient cells restores this defective
TOR signaling. Additionally, inactivation of the Oma1 ortholog in the human fungal pathogen Candida albicans also alters TOR
signaling and, unexpectedly, leads to increased resistance to neutrophil killing and virulence in the invertebrate animal model
Galleria mellonella. Our findings reveal a novel and evolutionarily conserved link between IMQC and TOR-mediated signaling
that regulates physiological plasticity and pancellular oxidative-stress responses.
Mounting evidence indicates that mitochondrial processes aretightly integrated with cellular signaling pathways (1–3).
Such integration enables rapid modulation of mitochondrial
functions upon homeostatic fluctuations in the intra- and extra-
cellular environment and adaptation of cellular metabolism in
response to changes within the mitochondrion. Studies in Saccha-
romyces cerevisiae have been instrumental for the elucidation of
evolutionarily conserved aspects of mitochondrion-linked signal-
ing. These analyses also provided insights into the mechanisms by
which cells in general and mitochondria in particular are pro-
tected from oxidative insults (4).
Reactive oxygen species (ROS), a by-product of mitochondrial
respiration, can damage a number of biological molecules,
thereby affecting mitochondrial and cellular well-being (5, 6). Ac-
cumulating ROS-elicited oxidative stress and damage have long
been known to be detrimental factors in many pathologies and
aging (5, 7, 8). On the other hand, many ROS are now recognized
as signaling molecules essential in multiple pathways, including
mitochondrion-nucleus communication and longevity regula-
tion (2, 6). The phenomenon, known as ROS adaptation, precon-
ditioning, or hormesis, is believed to be one of the ways by which
reduced signaling via the TOR pathway leads to stress-protective
effects (2, 9). This effect partly stems from the derepression,
through TOR inhibition, of the downstream signaling branch of
the TOR pathway that includes the kinase Rim15 and a stress/
nutrient signaling node containing the transcription factors Gis1
and the functionally redundant Msn2/Msn4 pair (4, 10). ROS
adaptation requires respiration and is temporally restricted to log-
arithmic and diauxic growth phases (11).
A network of conserved proteases known as intramitochon-
drial quality control (IMQC) is central to normal mitochondrial
activities (12). Studies in S. cerevisiae established that a specific
IMQC protease, Oma1, is important in mitochondrial stress tol-
erance (13). This ATP-independent protease resides in the inner
mitochondrial membrane (IM) as a high-mass complex and is
dormant under physiological conditions (13–16). Conditions of
mitochondrial stress, including acute treatment with H2O2 or re-
spiratory uncoupling, lead to rapid activation of Oma1 through
destabilization of the Oma1 oligomer (13, 16). Consistent with the
protease’s stress response role, yeast cells lacking functional Oma1
are vulnerable to oxidative stress (13). However, in the context of
cellular physiology, it remains unclear how Oma1 promotes resis-
tance to oxidative insults.
Here, using the S. cerevisiae model, we demonstrate that loss of
Oma1 leads to elevated ROS production during active growth.
Genetic and biochemical analyses indicate that ROS emitted by
Oma1-deficient mitochondria act as an adaptation signal that im-
pinges on the conserved TORC1-Rim15-Msn2/Msn4 signaling
pathway regulating stress survival responses. In addition, we show
that inactivation of the Oma1 ortholog in the human fungal
pathogen Candida albicans also modulates TOR signaling. This
unexpectedly promotes survival of the pathogen in human neu-
trophils and enhances its virulence. Our findings reveal a novel
link between IMQC and ROS-modulated TOR signaling in the
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regulation of physiological plasticity and pancellular stress re-
sponses.
MATERIALS AND METHODS
Yeast strains, vectors, and media. The S. cerevisiae strains used in this
study were isogenic to the W303 genetic background. A detailed descrip-
tion of the strains is provided in Table 1. Deletions of the indicated ORFs
were performed with aURA3MX cassette as described previously (13) and
followed by marker elimination through culturing on 5-fluoroorotic acid
(5-FOA) plates. All deletions were confirmed by PCR. The pRS415-
OMA1-6His-Myc, pRS415-OMA1-6His-Myc H203A (13), pADH1-
Msn2-GFP (17), and pCUP1-6Myc-Cki1 (2–200) (18) plasmids were
used to transform the indicated strains.
Cells were cultured in standard yeast extract-peptone (YP) or syn-
thetic complete (SC) medium supplemented with appropriate nutrients
and either 2% glucose, 2% galactose, or 2% glycerol-lactate as a sole car-
bon source.
Construction of a C. albicans oma1/ mutant. C. albicans strain
SC5314 (a clinical isolate from the blood; clade 1) (19) was used to gen-
erate the oma1/ mutant by utilizing a NAT1-Clox deletion cassette
TABLE 1 Genotypes and sources of yeast strains used in this study
Strain or key
element(s) Genotype Reference or source
W303-1B MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 D. Winge
W303-2A MATa ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 A. Barrientos
oma1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 oma1::TRP1 13
WT [rho0] MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 [rho0] This study
oma1 [rho0] MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 oma1::TRP1 [rho0] This study
tor1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 tor1::kanMX4 A. Barrientos
tor1 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 tor1::kanMX4 oma1::URA3MX This study
yme1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 yme1::HIS3MX6 13
yme1 oma1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 yme1::HIS3MX6 oma1::CaURA3 13
yta10 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 yta10::HIS3 D. Winge
yta10 oma1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 yta10::HIS3MX6 oma1::TRP1 13
pcp1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 pcp1::TRP1 13
pcp1 oma1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 pcp1::TRP1 oma1::URA3MX 13
cox5a MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 1 cox5a::HIS3 D. Winge
cox5a oma1 MAT ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 1 cox5a::HIS3 oma1::CaURA3 This study
sch9 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 sch9::kanMX4 A. Barrientos
sch9 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 sch9::kanMX4 oma1::URA3MX This study
sch9 oma1 tor1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 sch9::kanMX4 oma1- tor1::URA3MX This study
rtg1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rtg1::TRP1 This study
rtg1 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rtg1::TRP1 oma1::URA3MX This study
rtg2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rtg2::URA3MX This study
rtg2 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rtg2- oma1::URA3MX This study
ras2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 ras2::URA3MX This study
ras2 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 ras2- oma1::URA3MX This study
pde2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pde2::URA3MX This study
pde2 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pde2- oma1::URA3MX This study
avo2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 avo2::URA3MX This study
avo2 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 avo2- oma1::URA3MX This study
rim15 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rim15::TRP1 This study
rim15 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rim15::TRP1 oma1::URA3MX This study
gis1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 gis1::URA3MX This study
gis1 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 gis1- oma1::URA3MX This study
msn2 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 msn2::URA3MX This study
msn4 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 msn4::URA3MX This study
msn2 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 msn2- oma1::URA3MX This study
msn4 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 msn4- oma1::URA3MX This study
msn2msn4 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 msn4-msn2::URA3MX This study
msn2msn4 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 msn4-msn2- oma1::URA3MX This study
pph21 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pph21::URA3MX This study
pph22 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pph22::URA3MX This study
pph21 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pph21- oma1::URA3MX This study
pph22 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pph22- oma1::URA3MX This study
pph21 pph22 oma1 MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 pph22- pph21- oma1::URA3MX This study
sch9 oma1 [rho0] MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 sch9::kanMX4 oma1::URA3MX [rho0] This study
tor1 oma1 [rho0] MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 tor1::kanMX4 oma1::URA3MX [rho0] This study
rim15 oma1 [rho0] MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 rim15::TRP1 oma1::URA3MX [rho0] This study
Npr1-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 NPR1-3HA::klTRP1 This study
oma1 Npr1-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 NPR1-3HA::klTRP1 oma1::URA3MX This study
tor1 Npr1-3HA MATa ade2-1 his3-1,15 leu2-3,112 trp1 ura3-1 NPR1-3HA::klTRP1 tor1::URA3MX This study
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developed by Shahana et al. (20). The mutant was obtained in two subse-
quent transformation rounds. First, an oma1::NAT1-Clox cassette was
PCR amplified from the plasmid pLNMCL (20) with 92-bp flanking ho-
mology to the 5= upstream region and 96-bp flanking homology to the 3=
downstream region of the OMA1 gene (primers OMA1_NAT1_F1, 5=-ATT
TATCCTGGAATGTTCACCAGCCCCCCCTTTAAACTTGCCTAC
AGTTGACCAATAACATTAGTCGAGGCAGATCAGTGGAAAAAT
ATTATTACGGCCAGTGAATTGTAATA-3=, and OMA1_NAT1_R1,
5=-TTGTTAGTCGATGTAAATGTAATACAAAATGTTTGGTGGTG
CTGGTAGTATAGGTGATGGTATTTCACCAATGGTATGGCCACC
AACACACCTTAGATCGGAATTAACCCTCACTAA-3=). The transfor-
mants with one inactivated allele were selected on nourseothricin (Nou)-
containing rich medium with 2.5 mM methionine and 2.5 mM cysteine.
The genotypes of heterozygous mutants were confirmed by diagnostic
PCR. Single colonies were then restreaked on yeast extract-peptone-dex-
trose (YPD) medium without supplementation to resolve the oma1::
NAT1-Clox cassette. The further selected Nou-susceptible (Nous) isolates
were used for the next round of transformation with the PCR-amplified
oma1::NAT1-Clox cassette (primers OMA1_NAT1_F2, 5=-TCT
CTGGGTTTCTATCACAACTTTTTTTTCTCTCTGGTTTCGAGTGGA
GCATGGAAAATGAATTTGCATTAGGGAAATAACAAGAGTAATAA
CCCAAATACGGCCAGTGAATTGTAATA-3=, and OMA1_NAT1_R2,
5=-GTGAGAGCCAAGAGGTAACAAAGAATAATCTATATTGAAT
ATTTAACTCTAAGCACAATGGTATAAAACTTCAAGTCTTGGTACCA
TGTACAAATCGGAATTAACCCTCACTAA-3=). The selected Nou-resis-
tant (Nour) mutants were analyzed by PCR to confirm the disruption of
both OMA1 alleles.
Growth conditions. Yeast cells were synchronized as described previ-
ously (21). Quantitative assessment of a strain’s survival under stress was
done through determination of CFU as described previously (13). Cul-
tures were grown to an A600 of 0.5 and treated with either 0.5 or 1 mM
H2O2 for 1 h. The cells were then plated on YP-glucose plates to determine
their ability to form viable colonies. Yeast cells for fluorescence micros-
copy were grown in synthetic selective medium and treated as described
above.
Fluorescence techniques.For fluorescence microscopy, synchronized
live cells were visualized using the Olympus IX81-FV5000 confocal laser
scanning microscope at 488- or 543-nm laser lines with a 100 oil lens.
Images were acquired and processed with Fluoview 500 software (Olym-
pus America). Fluoresence-activated cell sorter (FACS) analyses were per-
formed as described previously (15). The oxygen radicals generated by
cells at various growth stages were quantitated using the fluorescent dyes
dehydroethidium (DHE) (Life Sciences), MitoSox (Life Sciences), and
dihydrorhodamine 123 (DHR123) (Cayman Chemical).
Killing of C. albicans strains by neutrophils. Polymorphonuclear
neutrophils (PMNs) were isolated from peripheral blood of healthy do-
nors by gradient density centrifugation in Histopaque 1077 and His-
topaque 1119 (Sigma) as described previously (22). The isolated PMNs
were resuspended in RPMI 1640 medium with fetal bovine serum (FBS)
(Life Technologies) at a concentration of 107 cells/ml. Neutrophil killing
was assayed as described previously (23), with minor modifications.
Briefly, the C. albicans cells were collected in mid-logarithmic phase by
centrifugation at 4,000 g for 5 min, counted, and resuspended in sterile
phosphate-buffered saline (PBS) at a concentration of 106 cells per ml. C.
albicans cells (200l) were incubated with 200 l of PMNs at a final ratio
of 1:10 and 200 l of RPMI medium. The cultures were incubated for 2 h
at 37°C under 5% CO2. The PMNs were lysed by addition of 100 l of
0.25% SDS and a short incubation at 30°C for 5 to 10 min. Ice-cold water
(900l) was added and vigorously mixed, and the mixture was incubated
with 50 U of DNase 1 in 100l 10 PBS for 15 min at 30°C; 100l of the
mixture was plated on YPD agar, and CFU were counted after 48 h at
30°C.
G. mellonella killing assay. Virulence assays were performed in the
Galleria mellonella larva infection model. Animals were injected with 6
104 C. albicans cells in 10 l of PBS or with PBS alone in the last proleg.
The larvae were maintained at 37°C, and viability was assessed twice daily.
Quantitative real-time PCR. Total RNA was prepared with an RNA
purification kit (Epicentre) by following the manufacturer’s instructions.
cDNA was prepared using a cDNA synthesis kit (Bio-Rad). Quantitative
real-time PCR was performed on a Bio-Rad iCycler using Sybr green
master mix (Bio-Rad). All samples were examined in triplicate, and the
values were normalized to the expression of -actin. The values were
calculated using the CT method. Statistical significance was deter-
mined using the threshold cycle (CT) value.
Miscellaneous biochemical assays. Catalase enzymatic activity was
determined as described previously (24). The activity was normalized to
total protein in the sample and is presented as micromoles of decomposed
hydrogen peroxide per minute and milligram of protein.
Whole-cell trichloroacetic acid (TCA) extracts were generated as pre-
viously described (15). The extracts were separated by SDS-PAGE and
transferred onto nitrocellulose. All the gels were run under the same ex-
perimental conditions. Immobilized polypeptides were incubated with
the indicated primary antibodies and horseradish peroxidase-conjugated
secondary antibodies and visualized with chemiluminescent substrates
(Thermo Scientific). Antiporin, antihemagglutinin (anti-HA), anti-Kar2,
anti-green fluorescent protein (anti-GFP), and anti-Pgk1 antibodies were
obtained from Life Technologies, Santa Cruz Biotechnology, Abcam, and
Sigma. Images were scanned and cropped to prepare the figures, with
cropping lines indicated. The intensities of the bands were quantified
using ImageJ software (http://rsb.info.nih.gov/ij/).
Statistical analyses. Statistical analyses were conducted using Mi-
crosoft Excel. At least three independent replicates were obtained for each
experiment presented. Unless otherwise specified, the results were ana-
lyzed using one-way analysis of variance (ANOVA) or an unpaired t test.
P values of0.05 were considered statistically significant.
RESULTS
Oma1-deficient cells are resistant to rapamycin and exhibit re-
duced TOR signaling. Oma1 activation in the mitochondria oc-
curs under various stress conditions, but beyond this, much re-
mains to be learned regarding its role in stress tolerance. To better
understand the role of Oma1 in mitochondrial stress tolerance, we
conducted a miniscreen aiming to test the fitness responses of the
Oma1-deficient mutant to 25 varied chemical compounds known
to impact the growth of yeast cells (Table 2). Our screen revealed
that, unlike wild-type (WT) cells, oma1 cells showed enhanced
resistance to compounds linked to TOR signaling, including caf-
feine and vanillin (25, 26) (Fig. 1A) and, most notably, the TOR
pathway-inactivating antibiotic rapamycin (Fig. 1A and 2A). This
effect is specific to Oma1 deficit, as loss of the other IM-bound
proteases, Pcp1 and Yme1 (i-AAA), or m-AAA (via deletion of its
Yta10 subunit) did not produce increased rapamycin tolerance
(Fig. 2A and data not shown). Moreover, the oma1-null allele is
dominant in the yme1 background but not in the yta10 back-
ground, as an oma1 yme1 double-deletion strain was also
mildly resistant to rapamycin. Importantly, lack of resistance to
the antibiotic oligomycin (Fig. 1B) and unaltered expression of
the key multidrug resistance proteins Pdr5 and Pdr15 (Fig. 1C)
indicate that the enhanced rapamycin tolerance of the oma1
strain is not due to the activated multidrug resistance pathway.
Collectively, these observations suggest that loss of Oma1 likely
exerts a negative effect on TOR signaling (27, 28).
The TOR complex 1 (TORC1) effector kinase Npr1, which
exists in both hyperphosphorylated and dephosphorylated forms,
exhibits a specific separation pattern on SDS-PAGE, with the for-
mer form migrating slower than the latter form (29). Published
data indicate that the hyperphosphorylated state is significantly
Bohovych et al.
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decreased in tor1 cells (29, 30). Therefore, to further corroborate
reduced TOR signaling in the oma1mutant, we chromosomally
tagged Npr1 with a 3HA epitope tag in WT, oma1, and tor1
cells and monitored its electrophoretic behavior by immunoblot-
ting. We reproducibly observed a significant decrease in the abun-
dance of hyperphosphorylated Npr1 in tor1 cells, as well as in
WT cells treated with rapamycin (Fig. 2B and C). Importantly, the
basal levels of phosphorylated Npr1 were significantly lower in
oma1 cells than in the WT (Fig. 2B and C), reflecting decreased
basal TORC1 activity. The expression levels of Tor1 and Tor2
(components of the TORC1 and TORC2 complexes, respectively)
were comparable between the oma1 strain and the wild-type
control (Fig. 2D). Altogether, our data suggest that certain aspects
of TORC1-related signaling are impeded in oma1 cells.
Loss of Oma1 impinges on the TORC1-Rim15-Msn2/Msn4
signaling axis. Loss of Oma1 may lead to elevated mitochondrial
ROS production during active growth, which acts as an adaptation
signal that impinges on the conserved TORC1 pathway (11). Sev-
eral signaling cascades intersect with TORC1 or converge on its
downstream targets (4, 31). To determine which facet of TOR
signaling is impeded by Oma1 loss-associated ROS emission, we
examined genetic interactions of OMA1 and genes encoding key
components of TORC1-related pathways (Fig. 3A). Deletion of
OMA1 in Sch9 kinase-deficient cells improved the growth of the
mutant on rapamycin-containing plates (Fig. 3B, row 4), indicat-
ing the dominant nature of the oma1-null allele in the sch9 back-
ground. Deletions of OMA1 in combination with genes encoding
retrograde pathway components (the transcription factor Rtg1 or
its sensor, Rtg2) did not significantly influence the rapamycin
phenotype of the cells in question (Fig. 3B, row 6, and data not
shown), probably because the rtg1 mutant alone also exhibited
resistance to the drug (Fig. 3B, line 5). Similarly, reduction of
cyclic AMP (cAMP)-protein kinase A (PKA) signaling through
deletion of the adenylate cyclase activator Ras2 (Fig. 3B, row 12) or
enhancement of PKA activity via disruption of the cAMP phos-
phodiesterase Pde2 (Fig. 3B, row 14) did not influence the rapa-
mycin resistance of oma1 cells. In contrast, the rapamycin resis-
tance of oma1 cells was abolished by deleting either Tor1 or its
downstream target, the PAS kinase Rim15 (Fig. 3B, rows 8 and
10), mimicking single deletions of these genes (32). Inactivation of
Avo2, a nonessential subunit of the rapamycin-insensitive com-
plex TORC2 (33), did not affect the rapamycin resistance of the
oma1 strain (Fig. 3C), indicating that loss of Oma1 primarily
reduces signaling via the Tor1-containing complex. In line with
these observations, TORC1 appears to be a limiting factor in the
oma1-mediated epistatic effects, as loss of TOR1 ablated the ra-
pamycin-resistant phenotype of the sch9 oma1 cells (Fig. 3D).
We thus conclude that modules of the TORC1-Rim15 signaling
axis are located downstream of OMA1.
Because the TORC1-Rim15 axis is known to control certain
aspects of pancellular stress responses (4), we examined the oxi-
dative-stress resistance of the above-mentioned strains by testing
their ability to form viable colonies following treatment with 1
mM H2O2 in log phase. As reported previously (13), oma1 cells
were sensitive to H2O2. Consistent with the dominant nature of
the oma1-null allele in the sch9 background, loss of SCH9did not
significantly improve the sensitivity of oma1 cells to H2O2. On
the other hand, deletion of TOR1 or RIM15 in the oma1 back-
ground conferred H2O2 resistance (Fig. 3E), which was markedly
increased for tor1 oma1 cells relative to the WT control. Loss of
TOR1 even enhanced the H2O2 resistance of the sch9 oma1
strain (data not shown), further indicating that sensitization of
oma1 cells to oxidants occurs via TORC1 signaling. Interest-
ingly, tor1 oma1 cells also exhibited a slight, but statistically
significant, increase in H2O2 survival relative to the tor1mutant,
suggesting that the relationship between Oma1 and TORC1 may
be more complex and involve additional factors.
In S. cerevisiae, the TORC1-Rim15 axis orchestrates several
transcription factors, including Gis1 and Msn2/Msn4 (4, 10).
While the above-described results suggest that the Msn2/Msn4-
mediated oxidative-stress response is altered in oma1 cells, it is
possible that Gis1 is also involved. To distinguish between these
scenarios, we analyzed the sensitivity of oma1 gis1 and oma1
msn2msn4 cells to rapamycin. The loss of Gis1 (Fig. 3F, rows 9
and 10), Msn2 (Fig. 3F, rows 3 and 4), or Msn4 (Fig. 3F, rows 5 and
6) in the oma1 background had no appreciable effect on drug
resistance. Conversely, the disruption of Msn2 and Msn4 in
oma1 cells abolished rapamycin resistance (Fig. 3F, row 8).
Moreover, the oma1msn2msn4 cells showed improved H2O2
survival relative to the oma1mutant alone (Fig. 3G). These data
indicate that deregulation of TORC1-Rim15-Msn2/Msn4 signal-
ing is a likely contributor to several phenotypes seen in the oma1
strain, including rapamycin resistance and oxidative-stress sensi-
tivity.
Oxidative-stress signaling is compromised in oma1 cells.
To better understand the reduced tolerance of Oma1-deficient
cells for oxidative stress, we monitored the expression of the two
Msn2/Msn4-controlled oxidative-stress-responsive genes: cata-
lase (CTT1) and manganese superoxide dismutase (SOD2).
Whereas expression of these genes was greatly upregulated in WT
cells treated with 0.5 mM H2O2, as reported previously (34), their
expression was largely unchanged in peroxide-treated oma1 cells
TABLE 2 Sensitivity of oma1 cells to various stressors
Compound or chemical
Concn
tested
Response (relative
to WT control)
NaCl 1 M No difference
Sorbitol 0.8 M No difference
CaCl2 100 mM No difference
CuCl2 2 mM No difference
CdCl2 2 mM No difference
NaAsO2 1 mM No difference
Buthionine sulfoximine (BSO) 5 mM No difference
Dithiothreitol (DTT) 4 mM No difference
Cycloheximide 1 g/ml No difference
Tunicamycin 1 g/ml No difference
Canavanine 10 g/ml No difference
Phenylmethylsulfonyl fluoride (PMSF) 4 mM No difference
2-Deoxyglucose (2-DG) 0.1% No difference
Dibutyryl cyclic AMP (dbcAMP) 1 mM No difference
Rapamycin 30 ng/ml Resistant
Myriocin 25 g/ml No difference
Caffeine 15 mM Resistant
Vanillin 10 mM Resistant
Concanamycin A 5 M No difference
Caspofungin 0.1 g/ml Sensitive
Iodoacetamide 30 M No difference
Antimycin A 5 M No difference
EDTA 5 mM No difference
Oligomycin 10 g/ml No difference
Mitochondrial Quality Control-Regulated Signaling
September 2016 Volume 36 Number 17 mcb.asm.org 2303Molecular and Cellular Biology
  
(Fig. 4A). Furthermore, attenuated CTT1 transcript levels in the
oma1mutant were reflected by reduced catalase activity follow-
ing H2O2 exposure (Fig. 4B). No significant difference in basal
catalase levels between WT and oma1 cells was observed.
Given that Msn2/Msn4 accumulate in the nucleus upon H2O2
treatment (35), we wanted to test if localization is altered in
oma1 cells upon cellular stress. Using confocal microscopy
(CFM), we examined the nuclear accumulation of GFP-tagged
Msn2 in glucose-grown cells exposed to 1 mM H2O2. Compared
with the WT control, oma1 cells accumulated significantly more
FIG1 Tolerance of the oma1mutant for selected chemical compounds. (A) Growth of WT and oma1 cells on plates with or without 10 mM vanillin, 30 ng/ml
rapamycin, 15 mM caffeine, and 0.1g/ml caspofungin. Synchronized cells were grown to mid-logarithmic stage (8 h of growth;A600 0.8), serially diluted, and
spotted onto the respective plates. Photographs were taken after 2 (No treatment) or 4 (plus compound) days at 28°C. (B) Growth of WT and oma1 strains on
plates containing increasing concentrations of oligomycin. The cells were handled as in panel A and spotted onto plates containing 10 g/ml or 250 g/ml
oligomycin. Photographs were taken after 2 days of incubation at 28°C. (C) Relative expression of PDR5 and PDR15 in the indicated strains. The error bars
indicate standard deviations (SD) (n 4 biological replicates); n.s., nonsignificant by Student’s t test. AU, arbitrary units.
FIG 2 Oma1-deficient cells are resistant to rapamycin and exhibit attenuated TOR activity. (A) Growth of the indicated strains on YPD plates with (	Rapa) or
without (
Rapa) 30 ng/ml rapamycin. Synchronized cells were grown to mid-log stage (8 h of growth; A600 0.8). Photographs were taken after 2 (
Rapa), 4
(	Rapa), or 6 (	Rapa, Prolonged incubation) days at 28°C. (B) WT, oma1, and tor1 strains expressing genomically tagged Npr1-HA were cultured in the
presence or absence of rapamycin. Log-phase cells were harvested, lysed, and analyzed by immunoblotting with antibodies against HA epitope and Kar2 (loading
control). Npr1HA and P-Npr1HA, dephosphorylated and hyperphosphorylated forms of the protein, respectively. The asterisk indicates an HA tag-cross-reacting
band. (C) Quantitation of the P-Npr1-HA form in WT, oma1, and tor1 cells. The error bars indicate standard errors of the mean (SEM) (n 3 biological
replicates). (D) Relative expression ofTOR1 andTOR2 in the indicated strains. The error bars indicate SD (n 4 biological replicates). P values were determined
as for Fig. 1 (n.s., nonsignificant; *, P 0.05 by Student’s t test). Ø, no detectable signal.
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Msn2-GFP in the nucleus upon peroxide treatment (Fig. 4C
and D). Importantly, Msn2-GFP steady-state levels were not al-
tered by the oma1 mutation (Fig. 4E). Similar results were ob-
tained when 0.1 mM or 0.5 mM H2O2 was used (Fig. 4F and G). To
test the specificity of this response, we examined Msn2-GFP local-
ization in response to a hyperosmotic insult. Unlike with H2O2
stress, wild-type and oma1 cells showed similar levels of nuclear
Msn2-GFP accumulation upon exposure to 1 M NaCl (Fig. 4H
and I). This is consistent with the finding that Oma1-deficient
cells show no sensitivity to NaCl. The more robust nuclear local-
ization of Msn2-GFP in response to NaCl treatment (relative to
H2O2 treatment) is likely due to the fact that Msn2/Msn4-medi-
ated core (environmental) stress responses are better “tuned” to-
ward more natural environmental stressors, such as osmotic
shock. Taken together, these data led us to conclude that Msn2/
Msn4-mediated oxidative-stress signaling is specifically com-
promised by Oma1 inactivation.
The TORC1 effector PP2A phosphatase contributes to ab-
normal Msn2 activity and impaired H2O2 tolerance in the
oma1 mutant. Despite the enhanced oxidative-stress-induced
nuclear localization of Msn2, its function appears to be impeded
in the oma1 mutant. A recent report implicated protein phos-
FIG 3 The TORC1-Rim15-Msn2/Msn4 signaling axis is downstream of OMA1. (A) Model demonstrating key components of mitochondrion-related signaling
in yeast. (B to D) Growth of the indicated strains on YPD plates with or without rapamycin (30 ng/ml). Cells were analyzed as for Fig. 1. (E) Oxidative-stress
survival of the indicated strains. Log-phase cultures (8 h; A600 0.5) were acutely treated with 1 mM H2O2 for 1 h. Samples were diluted to 300 cells and plated
for survival on YPD plates. The number of CFU was determined after 2 days at 28°C. The bars show means and SD (n 5). *, P 0.05; **, P 0.01 by Student’s
t test and one-way ANOVA. (F) Growth of indicated strains on YPD and YPD-plus-Rapa plates. (G) H2O2 stress survival of the indicated strains.
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phatase 2A (PP2A) in facilitating Msn2/Msn4 association with
chromatin via modulation of nuclear sequestration mechanisms
in response to signals from TORC1 (17). Moreover, alterations in
TORC1 cues can attenuate the transcriptional activity of Msn2/
Msn4 via several factors, including PP2A phosphatase (36). That
is, response to H2O2 treatment requires not only nuclear translo-
cation of the Msn2/Msn4 complex but also its activation via
PP2A-mediated mechanisms (Fig. 5A). Therefore, we sought to
test if loss of the catalytic subunits of PP2A, Pph21 and Pph22,
would affect the rapamycin resistance of the oma1 strain. Delet-
ing PPH21 or PPH22 only slightly attenuated the phenotype of
oma1 cells. However, the oma1 pph21 pph22 triple mutant
FIG 4 Oxidative- but not osmotic-stress response mediated via the Msn2/Msn4 signaling node is altered in oma1 cells. (A) Transcript changes in synchronized
WT and oma1 cells in response to acute treatment with 0.5 mM H2O2. Relative transcript levels ofOMA1, cytosolic catalase (CTT1), and manganese superoxide
dismutase (SOD2) were assessed by quantitative PCR (qPCR) (n  5 independent experiments). (B) Catalase activity in whole-cell extracts derived from the
indicated cells (n 3 biological replicates). The bars show mean values and SD. (C and D) Nuclear accumulation of Msn2-GFP in 1 mM H2O2-exposed WT and
oma1 cells. (C) Representative images showing Msn2-GFP localization at 15 min posttreatment. (D) Quantitation of time-dependent nuclear accumulation of
Msn2-GFP. The error bars indicate SD (n 3, with 800 cells per biological replicate). (E) Steady-state levels of Msn2-GFP in WT and oma1 cell lysates. Proteins
were visualized with antibodies against the GFP moiety. (F and G) Nuclear accumulation of Msn2-GFP in 0.1 or 0.5 mM H2O2-exposed WT and oma1 cells. (F)
Representative images showing Msn2-GFP localization at 15 min posttreatment. (G) Quantitation of nucleus-localized Msn2-GFP. The error bars indicate SD
(n 3, with 800 cells per biological replicate). (H and I) Nuclear accumulation of Msn2-GFP in response to 1 M NaCl was analyzed as for panels C, F, and G. n.s.,
nonsignificant; *, P 0.05; **, P 0.01; ***, P 0.001 by Student’s t test.
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was very sensitive to this TORC1 inhibitor (Fig. 5B, row 8), re-
flecting the importance of PP2A in the rapamycin resistance of
Oma1-deficient cells. Moreover, combined loss of PPH21 and
PPH22 in oma1 cells restored their tolerance for acute H2O2
stress (Fig. 5C).
Deletion of the PP2A subunits in the oma1 strain resulted in
even higher nuclear accumulation of Msn2-GFP reporter than in
the control strains (Fig. 5D and E). These observations are consis-
tent with the idea that PP2A functions downstream of the events
leading to nuclear accumulation of Msn2/Msn4. These data indi-
cate that the PP2A phosphatase modulates Msn2/Msn4 activity
and oxidative-stress sensitivity in the oma1 strain.
Transiently elevatedROSproduction contributes to reduced
TOR signaling in Oma1-deficient cells. Mitochondria generate
cues that regulate a number of cellular processes, including oxida-
tive-stress tolerance (11, 37–40). Mitochondrion-emitted ROS
appear to be central to many of these events (6). We recently
demonstrated that loss of Oma1 leads to unbalanced respiration
and enhanced ROS production (41). To further explore this ob-
servation, we stained synchronized WT and oma1 cells at various
growth stages with the superoxide (O2
·
)-sensitive dye DHE and
monitored their fluorescence by flow cytometry. Consistent with
previous reports (11), we observed low basal levels of DHE fluo-
rescence in exponentially growing WT cells. We also confirmed
the increase in endogenous O2
·
 production in stationary-phase
cells. However, we found that during log phase, oma1 cells re-
producibly accumulate relatively high levels of O2
·
 (Fig. 6A). The
superoxide levels were comparable in diauxic oma1 and WT cells
(data not shown), indicating that ROS levels in WT cells eventu-
ally catch up to those in the oma1 mutant. We therefore tested
ROS levels in stationary phase and found that the DHE staining in
the oma1 mutant was comparable to that in the WT (Fig. 6A).
Similar results were obtained with the O2
·
-specific dye MitoSox
(not shown) and with the H2O2-specific dye dihydrorhodamine
123 (Fig. 6B). Because the temporal increase in ROS and ele-
vated oxygen consumption in exponential-phase oma1 cells
FIG 5 Mitochondrial function, ROS production, and antioxidant defense in the oma1 strain. (A) Schematic showing the relationship between the PP2A
phosphatase and the transcriptional factor Msn2. (B) Growth of the indicated strains on YPD plates with or without rapamycin (30 ng/ml). (C) Oxidative-stress
survival of the indicated strains determined as described for Fig. 3E. (D and E) Nuclear accumulation of Msn2-GFP in the indicated strains at 15 min after
treatment with 1 mM H2O2. (D) Representative confocal microscopy images. (E) Quantitation of nucleus-localized Msn2-GFP. Cells were handled and analyzed
as described for Fig. 3D. *, P 0.05; **, P 0.01; ***, P 0.001 by Student’s t test.
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partially phenocopy mutants with reduced TOR signaling (11) (Fig.
6A and B), we hypothesized that reduced TORC1 activity in oma1
cells may be a consequence of transiently elevated intracellular ROS.
To examine the link between elevated radicals in log-phase
oma1 cells and deregulated TOR signaling, we tested whether
preventing ROS accumulation in these cells ameliorates the rapa-
mycin resistance of the strain. Electron transport chain (ETC)
complexes are one of the primary sources of ROS in a cell (6).
Thus, we compared the rapamycin growth phenotypes of oma1
strains with ([rho	]) and without ([rho0]) the mitochondrial ge-
FIG 6 Transiently elevated ROS contribute to rapamycin resistance of the oma1 mutant. (A and B) ROS production determined by FACS analysis of
synchronized DHE-stained (A) or DHR123-stained (B) WT and oma1 cells at log (Log.) (A600 0.5 6 h postinoculation) and stationary (Stat.) (A600 3.0 12
h postinoculation) stages. The data show mean values and SD (n  3 to 5 biological repeats). (C) Growth of the indicated strains with (	) or without (0)
mtDNA. (D to G) Growth of antioxidant-pretreated WT and oma1 strains. Synchronized exponential-phase cells (8 h of growth; A600 0.8) cultured with or
without 5M sodium ascorbate (D) or 20 mM the ROS scavenger Tiron (F) were analyzed as described above. (E and G) Ascorbate pretreatment (E) and Tiron
pretreatment (G) showing growth of the same strains analyzed in stationary phase (24 h of growth; A600 8.0). n.s., nonsignificant; **, P 0.01; ***, P 0.001
by Student’s t test.
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nome. Loss of mitochondrial DNA (mtDNA) (encoding several
key ETC subunits) completely abrogated the rapamycin resistance
of the oma1 mutant (Fig. 6C). Moreover, pretreatment of log-
phase oma1 cells (A600 0.5) with the ROS scavenger ascorbate
(Fig. 6D) or the antioxidant Tiron (Fig. 6F) negated their ability to
grow on rapamycin-containing plates. In line with the idea of
hormetic-like ROS adaptation in exponential-phase cells (11),
postdiauxic oma1 cells were unable to survive on rapamycin
plates (Fig. 6E and G). This is likely due to the fact that stationary-
phase oma1 cells do not exhibit elevated ROS (Fig. 6B); the pre-
viously reported progressive decline of respiratory function in
these cells may also contribute to the loss of rapamycin resistance.
Interestingly, the pretreatment of stationary WT and oma1 cul-
tures with antioxidants had an advantageous effect on their
growth on rapamycin plates, suggesting that dampening ROS in
postdiauxic cells may be beneficial for their survival. Collectively,
these data indicate that a transient increase in mitochondrial ROS
modulates TORC1-related signaling in oma1 cells.
The Oma1 homolog is necessary for TOR signaling-medi-
ated physiological responses in C. albicans. We asked if the im-
pact of Oma1 upon TOR signaling is evolutionarily conserved. To
explore this, we examined the role of the Oma1 ortholog in an
evolutionarily distant yeast, the human pathogen C. albicans. We
deleted both alleles of orf19.3827 (whose products had 45.2% se-
quence identity to the S. cerevisiae Oma1 protein) to construct a
homozygous null mutant in the diploid yeast (Fig. 7A). Like the S.
cerevisiae oma1 strain, the C. albicans oma1/ mutant dis-
played no obvious phenotype under standard growth conditions.
However, consistent with S. cerevisiae data, upon stress with 5 mM
H2O2, C. albicans oma1/ cells displayed mild growth impair-
ment. Additionally, the survival of the strain was affected by the
drug caspofungin (Fig. 7B). Notably, S. cerevisiae oma1 cells
were also found to be caspofungin sensitive in our miniscreen
(Fig. 1A). Most significantly, C. albicans oma1/ cells exhibited
marked resistance to rapamycin (Fig. 7B).
TOR pathway components have been implicated as virulence-
mediating factors in C. albicans (42, 43). We therefore examined
the virulence of the C. albicans oma1/ strain by two indepen-
dent approaches. First, we tested the survival of WT and oma1/
cells upon incubation with human PMNs isolated from three dif-
FIG 7 Loss of Oma1 impinges on TOR signaling and promotes virulence in C. albicans. (A) PCR confirming homozygous deletion of orf19.3827/OMA1 in C.
albicans strain SC5314. (B) Sensitivity of the SC5314 and oma1/ strains to various stressors. Mid-log-stage cells were grown on YPD plates containing 5 mM
H2O2, 0.1g/ml caspofungin (Caspo), or 0.4g/ml rapamycin (Rapa). The plates were placed in the 30°C static incubator, and photographs were taken 24 h after
spotting. (C) Survival of C. albicans strains in human neutrophils. The indicated strains (1 106 cells) were isolated, washed, and cocultured with 1 107 RPMI
medium-plus-FBS-treated polymorphonuclear granulocytes from 3 unrelated healthy donors. Following 2-h coincubation at 37°C, pathogen cells were reiso-
lated and plated for survival. The viable colonies were assessed after 48 h at 30°C. (D and E) Survival ofG.mellonella larvae infected with the indicated strains. The
larvae were injected with cells or buffer and monitored for 5 days at 37°C. n  25 subjects per replicate for each group plus 10 noninjected animals (nonma-
nipulated control). Three biological replicates of each experiment were conducted, and two independent isolates of the oma1/ strain were tested. (D)
Kaplan-Meier survival plot of animals infected with the indicated strains (the results show the data pooled for a single comparison; n 75 for each strain). P
values were determined using log rank statistics. (E) Complementary data showing the percentage of G. mellonella killing SEM; P values were determined as
for Fig. 1. *, P 0.05; **, P 0.01 by Student’s t test.
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ferent donors. Surprisingly, the oma1/ cells exhibited increased
resistance to PMN killing (Fig. 7C). This may be due to the higher
metabolic plasticity of C. albicans and the evolutionary “rewiring”
of the TOR pathway at the level of the Msn2/Msn4 node, because,
unlike S. cerevisiae, these transcription factors do not play a signif-
icant role in the pathogen’s responses to oxidative stress (44, 45).
Next, we tested the virulence of the oma1/ strain in the estab-
lished G. mellonella larval model of systemic Candida infection
(46). The larvae injected with rapamycin-resistant oma1/ cells
displayed increased virulence, particularly at day 5 of infection
(Fig. 7D and E). Together, our data indicate that, as in S. cerevisiae,
loss of Oma1 in C. albicans impinges on TOR signaling, which
impacts on specific physiological properties of the pathogen, in-
cluding its virulence.
DISCUSSION
Here, we show that loss of the conserved protease Oma1 in yeast
reduces signaling via the TORC1-Rim15-Msn2/Msn4 axis,
thereby interfering with oxidative-stress responses. These data
support a recent model (11, 38, 39) postulating the existence of a
transient, adaptive ROS signal necessary for survival in stationary
phase in TOR signaling mutants. Our novel finding is the identi-
fication of an upstream, mitochondrion-localized, modulator of
TOR signaling. Cells lacking Oma1 display (i) elevated resistance
to rapamycin, (ii) increased respiration and ROS production dur-
ing logarithmic growth, and (iii) reduced phosphorylation of the
TORC1 effector protein Npr1. These traits are characteristic of
strains with reduced TOR activity (11, 28, 29, 47). The loss of the
TORC1 subunit Tor1 or its downstream target kinase, Rim15, in
oma1 cells abolishes these traits. Epistatic interactions between
OMA1 and SCH9 or RTG1 suggest that these branch point signal-
ing elements are not directly involved. Moreover, Tor1 appears to
be a limiting factor in these genetic interactions. The signaling
deficit in oma1 cells is also not due to attenuation of PKA or Ras
signaling. Two factors appear to be critical for oma1 phenotypes.
In line with previous reports (11, 37), transient accumulation of
ROS in the actively growing oma1 strain is likely a key contrib-
utor to altered TOR signaling. Reducing ROS in logarithmic-
phase oma1 cells with antioxidants, or by genetically blocking
respiration, remedies malfunctioning TORC signal transduction.
The enhancement in the respiratory capacity of log-phase oma1
cells likely defines the specificity of the phenotype, because the
strains defective in other IM proteases (yme1, yta10, and
pcp1) are, to various degrees, respiratory deficient. Consistent
with this postulate is the lack of rapamycin resistance in the
oma1 yta10 mutant, wherein loss of the Yta10 subunit of the
m-AAA protease results in the complete loss of respiration. It is
also noteworthy that the results of our antioxidant pretreatment
experiments are in line with the model whereby elevated levels of
ROS may be advantageous in younger cells but become detrimen-
tal in aged cells (48).
How does suspended TORC1-Rim15 signaling relate to vul-
nerability of oma1 cells to stress? Reportedly, alterations in
TORC1 cues attenuate the transcriptional activity of Msn2/Msn4
via several factors, including PP2A phosphatase (17, 36). Our
study reveals that, despite the enhanced nuclear localization of
Msn2 (and presumably Msn4) in response to acute oxidative
stress, the expression of Msn2/Msn4-controlled genes is not sig-
nificantly changed in oma1 cells. This effect is specific to oxida-
tive insults and appears to underpin the reduced oxidative stress
tolerance and rapamycin resistance of oma1 cells (Fig. 8). Re-
markably, inactivation of PP2A alleviates both phenotypes. It is
noteworthy that in the W303 genetic background used in this
study, oxidation/nuclear retention of another oxidative-stress-re-
sponsive redox-sensitive transcriptional factor, Yap1, is largely
Hyr1/Gpx3 independent and mediated via the Msn2/Msn4-con-
trolled Srx1-Tsa1 peroxiredoxin relay (49, 50). This situation may
therefore potentiate the effect of impaired Msn2/Msn4 function
and further contribute to increased sensitivity of oma1 cells to
H2O2.
FIG 8 Speculative model of how Oma1 loss affects the TORC1 pathway-dependent oxidative-stress response. Depletion of Oma1 is associated with enhanced
production of mitochondrial ROS during exponential growth. Elevated ROS levels exert a modulatory effect on TORC1 signaling, which results in reduced
communication via the TORC1-Rim15 axis and reduces activity of the PP2A phosphatase. These alterations lead to improper nuclear transport and/or retention
of the Msn2/Msn4 transcriptional complex, thereby reducing the expression of Msn2/Msn4-controlled genes in response to acute oxidative stress. We acknowl-
edge that reduced TORC1 signaling may exert additional effects (not shown in the cartoon) that can also contribute to the reduced oxidative-stress tolerance and
rapamycin resistance of oma1 cells. Black, normal/active signaling; red, inhibited signaling; dashed gray, affected signaling or inhibition.
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The association of Oma1 with TOR signaling is not restricted
to baker’s yeast. Deletion of the OMA1 ortholog in C. albicans
results in marked resistance to rapamycin, indicating suspended
TOR signaling. However, the modulatory effect of Oma1 loss inC.
albicans differs from that in S. cerevisiae, likely due to higher met-
abolic plasticity of C. albicans and the “rewiring” of interactions
between TOR and Msn2/Msn4 signaling in the pathogen (44, 45).
Consistent with TOR signaling being reduced in the C. albicans
oma1/mutant, this strain shows significant enhancement of its
resistance to phagocytic killing and its virulence.
Beyond the physiological relevance, our findings have biomed-
ical importance. First, we identify Oma1 as a novel factor that
integrates mitochondrial function with TOR signaling. Our data
may provide explanations for some unexpected metabolic pheno-
types in Oma1 knockout mice (51). Second, the enhanced rapa-
mycin resistance and virulence observed in Oma1-deficient C. al-
bicans cells reveals a new potential role of Oma1 as a therapeutic
target/risk factor in systemic candidiasis. It is also possible that
additional mitochondrial proteins, whose depletion can exert
similar modulatory effects on TOR signaling, exist. Further stud-
ies are warranted to address these exciting questions.
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